Theravance Biopharma, Inc. (TBPH) Balance sheet

Market cap

$849.63M

P/E ratio

	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	89	113	345	89	379	59	82	91	299	40	39	169
Total cash & short-term investments	89	113	345	89	379	59	82	91	299	40	39	169
Accounts receivable, net	0	2	1	2	1	-	-	-	-	-	-	-
Inventories	13	10	12	17	-	-	-	-	-	-	-	-
Total current assets	275	237	529	379	533	338	393	250	353	134	161	418
Property, plant and equipment, net	10	10	8	10	13	13	16	14	12	9	7	6
Marketable securities, non-current	51	43	92	42	12	5	-	-	-	-	-	11
Total assets	338	300	639	441	560	409	469	375	607	382	354	486
Accounts payable	10	19	2	6	9	5	7	3	2	2	2	3
Total current liabilities	41	49	49	63	99	112	124	59	29	25	32	38
Retained earnings	-139	-322	-512	-798	-1,012	-1,249	-1,527	-1,726	-854	-909	-966	-860
Stockholders' equity	290	243	350	115	-52	-224	-304	-339	442	213	176	297
Working capital						-	-	-	-	-	-	-